imiquimod has been researched along with Dermatosclerosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aranegui, B; Jiménez-Reyes, J | 1 |
Bielsa Marsol, I | 1 |
Haddad, E; Hatami, A; Marcoux, D; McCuaig, CC; Piram, M; Powell, J; Saint-Cyr, C | 1 |
Bianchi, L; Campione, E; Chimenti, S; Diluvio, L; Orlandi, A; Paternò, EJ | 1 |
Doria, AS; Laxer, RM; Mohanta, A; Pope, E; Theriault, M | 1 |
Dytoc, M; Fiorillo, L; Man, J; Sawyer, D; Ting, PT | 1 |
2 review(s) available for imiquimod and Dermatosclerosis
Article | Year |
---|---|
Morphea in Childhood: An Update.
Topics: Acute-Phase Proteins; Bosentan; Calcitriol; Child; Child, Preschool; Female; Humans; Imiquimod; Immunosuppressive Agents; Incidence; Male; Phototherapy; Prevalence; Prognosis; Quality of Life; Scleroderma, Localized; Vitamin D | 2018 |
Update on the classification and treatment of localized scleroderma.
Topics: Algorithms; Aminoquinolines; Clinical Trials as Topic; Eosinophilia; Fasciitis; Glucocorticoids; Humans; Imiquimod; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Physical Therapy Modalities; Recurrence; Scleroderma, Localized; Severity of Illness Index | 2013 |
1 trial(s) available for imiquimod and Dermatosclerosis
Article | Year |
---|---|
Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study.
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Child; Dermis; Female; Humans; Imiquimod; Male; Ointments; Pilot Projects; Prospective Studies; Scleroderma, Localized; Skin Ulcer; Treatment Outcome; Ultrasonography | 2011 |
3 other study(ies) available for imiquimod and Dermatosclerosis
Article | Year |
---|---|
Short- and long-term outcome of linear morphoea in children.
Topics: Adolescent; Adrenal Cortex Hormones; Age of Onset; Aminoquinolines; Calcitriol; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Imiquimod; Male; Methotrexate; Ointments; Phototherapy; Retrospective Studies; Scleroderma, Localized; Tacrolimus; Treatment Outcome; Vitamin A; Vitamin E | 2013 |
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Biopsy, Needle; Dermoscopy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Risk Assessment; Sampling Studies; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
First case series on the use of imiquimod for morphoea.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aminoquinolines; Child; Drug Evaluation; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome | 2005 |